Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anke Pisters-van Roy

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Market Access & Health Policy|November 8, 2021
Manufacturers' views on outcome-based agreementsSahar Barjestehvan Waalwijk van Doorn-Khosrovani, Lonneke Timmers, Anke Pisters-van Roy, et al.
The Lancet. Oncology|July 6, 2023
Adjuvant immune checkpoint blockade revisitedSahar Barjesteh van Waalwijk van Doorn-Khosrovani, Atse Huisman, Anke Pisters-van Roy, et al.
Frontiers in Medicine|October 10, 2022
Outcome-based reimbursement in Central-Eastern Europe and Middle-EastIldikó Ádám, Marcelien Callenbach, Bertalan Németh, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Market Access & Health Policy|November 8, 2021
Manufacturers' views on outcome-based agreementsSahar Barjestehvan Waalwijk van Doorn-Khosrovani, Lonneke Timmers, Anke Pisters-van Roy, et al.
The Lancet. Oncology|July 6, 2023
Adjuvant immune checkpoint blockade revisitedSahar Barjesteh van Waalwijk van Doorn-Khosrovani, Atse Huisman, Anke Pisters-van Roy, et al.
Frontiers in Medicine|October 10, 2022
Outcome-based reimbursement in Central-Eastern Europe and Middle-EastIldikó Ádám, Marcelien Callenbach, Bertalan Németh, et al.
Pageof 1